세계의 소아 중환자 치료 시장(-2030년) : 제품 유형, 치료 유형, 연령층, 치료 환경, 지역별 예측 및 분석

According to Stratistics MRC, the Global Pediatric Critical Care Market is accounted for $28.9 billion in 2024 and is expected to reach $42.4 billion by 2030 growing at a CAGR of 6.6% during the forecast period. A specialty area of medicine called pediatric critical care is dedicated to offering complete medical care to critically ill newborns, kids, and teenagers. It entails specialized treatments, advanced life support, and ongoing monitoring in a pediatric intensive care unit (PICU). The objective of this multidisciplinary field is to stabilize and enhance the health of young patients by treating life-threatening conditions like severe infections, respiratory failure, trauma, and post-surgical complications.

According to the Health Resources and Services Administration (HRSA) 2024 report, there were 279,194 primary care physicians in the U.S. in 2022.

Market Dynamics:

Driver:

Rising prevalence of pediatric critical conditions

The increasing incidence of critical conditions such as congenital heart diseases, respiratory disorders, and sepsis among children is a major driver of the pediatric critical care market. Advancements in diagnostic tools and medical technologies have improved survival rates, necessitating specialized intensive care. Additionally, rising awareness about early intervention and the growing number of pediatric intensive care units (PICUs) globally further fuel market growth. The demand for better healthcare infrastructure and resources to manage complex pediatric cases underscores the market's expansion.

Restraint:

Stringent regulations and approvals

Regulatory bodies require rigorous clinical trials to ensure safety and efficacy for pediatric use, leading to delays in product approvals. These processes increase development costs, discouraging manufacturers from investing in innovative solutions. Furthermore, the lack of standardized guidelines across regions complicates the regulatory landscape, limiting the availability of advanced treatments in certain markets.

Opportunity:

Telemedicine in pediatric critical care

Telemedicine enables remote monitoring and consultation, improving access to specialized care in underserved regions. It reduces the need for patient transfers, optimizing resource utilization in PICUs. With advancements in telehealth technology and increasing adoption during the COVID-19 pandemic, telemedicine is becoming a vital tool for enhancing care delivery, particularly in rural or low-resource settings.

Threat:

Rising concerns over drug and equipment safety

Concerns regarding the safety of drugs and medical equipment used in pediatric critical care pose a threat to market growth. Adverse drug reactions (ADRs) and off-label drug use are prevalent due to limited pediatric-specific formulations. Similarly, the lack of child-friendly medical devices increases risks during treatment. These challenges necessitate stringent safety standards and innovations tailored to pediatric needs, which can delay product availability and adoption.

Covid-19 Impact:

The COVID-19 pandemic significantly disrupted the pediatric critical care market due to reduced hospital admissions and resource reallocation towards adult ICUs. Fear of virus exposure led to delayed healthcare access for children, worsening outcomes for critical conditions. However, the pandemic accelerated telemedicine adoption, enabling remote consultations and continuity of care. While PICU admissions declined temporarily, post-pandemic recovery efforts have driven renewed investments in healthcare infrastructure, supporting long-term growth.

The monitoring and diagnostic devices segment is expected to be the largest during the forecast period

The monitoring and diagnostic devices segment is expected to account for the largest market share during the forecast period due to their essential role in managing critically ill children. These devices provide real-time data on vital parameters like heart rate, oxygen levels, and blood pressure, enabling timely interventions. The segment's growth is driven by advancements in non-invasive technologies and increasing adoption of remote monitoring systems. Their widespread use across PICUs ensures accurate diagnosis and effective treatment planning, solidifying their position in the market.

The cardiovascular conditions segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cardiovascular conditions segment is predicted to witness the highest growth rate due to rising incidences of congenital heart diseases and advancements in surgical interventions. Specialized cardiac intensive care units (CICUs) are increasingly being established to address complex cases requiring critical care. Innovations in medical devices like ECMO (extracorporeal membrane oxygenation) systems further enhance survival rates for severe cardiovascular conditions, driving rapid growth in this segment.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its high pediatric population and increasing healthcare investments. Countries like China and India are witnessing rising PICU admissions driven by improved access to healthcare services and awareness about neonatal care. Government initiatives supporting healthcare infrastructure development further bolster regional growth. The presence of global companies expanding their footprint in Asia Pacific also contributes significantly to its dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rapid advancements in healthcare technologies and growing demand for specialized pediatric care. The region's large population base, coupled with increasing prevalence of chronic conditions like congenital heart diseases, fuels market expansion. Investments in training programs for healthcare professionals and the establishment of new PICUs enhance service delivery, ensuring robust growth throughout the forecast period.

Key players in the market

Some of the key players in Pediatric Critical Care Market include Birmingham Women's and Children's NHS Foundation Trust, The Children's Hospital of Philadelphia, Memorial Sloan Kettering Cancer Center, Great Ormond Street Hospital, The Hospital for Sick Children, Weill Cornell Medicine, Boston Children's Hospital, John Muir Health, Alder Hey Children's NHS Foundation Trust, Ann & Robert H. Lurie Children's Hospital of Chicago, Dragerwerk AG & Co. KGaA, Cardinal Health, Koninklijke Philips N.V., Medtronic and GE Healthcare.

Key Developments:

In September 2024, Children's Hospital Association (CHA), Cardinal Health, and Zero Suicide Institute (ZSI) celebrate early success of the Preventing Youth Suicide Collaborative, a collaborative funded by the Cardinal Health Foundation, led by CHA, and informed by ZSI's prevention expertise.

In April 2024, Drager, a global leader in medical and safety technology, announces the launch of Vista 300 in India, a groundbreaking patient monitoring system designed to streamline information flow across hospital departments. The Vista 300 system offers continuous end-to-end data transfer from the patient's bed to the Hospital Information System (HIS), providing medical professionals with access to critical clinical care information along the entire patient pathway, from the Emergency Room (ER) to the Intensive Care Unit (ICU) and Neonatal Intensive Care Unit (NICU).

In July 2023, Medanta group of hospitals, a leading healthcare service provider, announced the launch of Tele-ICU services in India as Medanta e-ICU project, in association with GE HealthCare, a leading global medical technology and digital solutions innovator, with a vision to nurture superspeciality based critical care practices. This association aims to transform healthcare delivery and address the existing gaps in critical care, with high level knowledge transfer via 24x7 Medanta e-ICU Command Centre, powered by cutting edge technology from GE HealthCare that equips both central and bedside medical teams.

Product Types Covered:

• Monitoring and Diagnostic Devices
• Life Support and Therapeutic Equipment
• Other Product Types

Treatment Types Covered:

• Respiratory Conditions
• Cardiovascular Conditions
• Neurological Conditions
• Infectious Diseases
• Oncology
• Surgical and Trauma Care

Age Groups Covered:

• Neonates (0-28 Days)
• Infants (1 Month-1 Year)
• Children (1-12 Years)
• Adolescents (12-18 Years)

Care Settings Covered:

• Hospitals
• Specialty Clinics
• Ambulatory Care Centers

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pediatric Critical Care Market, By Product Type

• 5.1 Introduction
• 5.2 Monitoring and Diagnostic Devices
  • 5.2.1 Vital Signs Monitors
  • 5.2.2 Capnography Monitors
  • 5.2.3 Pulse Oximeters
  • 5.2.4 Blood Gas Analyzers
  • 5.2.5 Neurological Monitoring Devices
  • 5.2.6 Imaging Equipment
  • 5.2.7 Point-of-Care Testing (POCT) Devices
• 5.3 Life Support and Therapeutic Equipment
  • 5.3.1 Ventilators
  • 5.3.2 ECMO Devices
  • 5.3.3 Dialysis/CRRT Machines
  • 5.3.4 Incubators/Warmers
  • 5.3.5 Defibrillators
  • 5.3.6 Anesthesia Machines
  • 5.3.7 Infusion Pumps
• 5.4 Other Product Types

6 Global Pediatric Critical Care Market, By Treatment Type

• 6.1 Introduction
• 6.2 Respiratory Conditions
• 6.3 Cardiovascular Conditions
• 6.4 Neurological Conditions
• 6.5 Infectious Diseases
• 6.6 Oncology
• 6.7 Surgical and Trauma Care

7 Global Pediatric Critical Care Market, By Age Group

• 7.1 Introduction
• 7.2 Neonates (0-28 Days)
• 7.3 Infants (1 Month-1 Year)
• 7.4 Children (1-12 Years)
• 7.5 Adolescents (12-18 Years)

8 Global Pediatric Critical Care Market, By Care Settings

• 8.1 Introduction
• 8.2 Hospitals
  • 8.2.1 Pediatric Intensive Care Units (PICUs)
  • 8.2.2 Neonatal Intensive Care Units (NICUs)
  • 8.2.3 Emergency Departments
  • 8.2.4 Children's Hospitals
• 8.3 Specialty Clinics
• 8.4 Ambulatory Care Centers

9 Global Pediatric Critical Care Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Birmingham Women's and Children's NHS Foundation Trust
• 11.2 The Children's Hospital of Philadelphia
• 11.3 Memorial Sloan Kettering Cancer Center
• 11.4 Great Ormond Street Hospital
• 11.5 The Hospital for Sick Children
• 11.6 Weill Cornell Medicine
• 11.7 Boston Children's Hospital
• 11.8 John Muir Health
• 11.9 Alder Hey Children's NHS Foundation Trust
• 11.10 Ann & Robert H. Lurie Children's Hospital of Chicago
• 11.11 Dragerwerk AG & Co. KGaA
• 11.12 Cardinal Health
• 11.13 Koninklijke Philips N.V.
• 11.14 Medtronic
• 11.15 GE Healthcare